The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain

Biomaterials

Volumn 29, Issue 2, 2008, Pages 238-246

  Huang, Rongqin ^a   Ke, Weilun ^a   Liu, Yang ^a   Jiang, Chen ^a   Pei, Yuanying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Brain targeting; Lactoferrin; Polyamidoamine; Receptor mediated gene delivery

Indexed keywords

BRAIN; ENDOTHELIAL CELLS; GENE EXPRESSION; LIGANDS; POLYETHYLENE GLYCOLS;

BRAIN TARGETING; BRAIN TARGETING LIGAND; LACTOFERRINS; POLYAMIDOAMINES; RECEPTOR MEDIATED GENE DELIVERY;

PROTEINS;

DNA; IODINE 125; LACTOFERRIN; MACROGOL; POLYAMIDOAMINE; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN CAPILLARY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FROZEN SECTION; GENE EXPRESSION; GENE VECTOR; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

ANIMALS; BRAIN; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; LACTOFERRIN; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; POLYAMINES;

EID: 35548959221     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.09.024     Document Type: Article

References (35)

1. Pardridge W.M. Drug and gene delivery to the brain: the vascular route. Neuron 36 4 (2002) 555-558
2. Schlachetzki F., Zhang Y., Boado R., and Pardridge W.M. Gene therapy of the brain: the trans-vascular approach. Neurology 62 8 (2004) 1275-1281
3. Shi N., Boado R.J., and Pardridge W.M. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res 18 8 (2001) 1091-1095
4. Gosk S., Vermehren C., Storm G., and Moos T. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J Cereb Blood Flow Metab 24 11 (2004) 1193-1204
5. Visser C.C., Voorwinden H., Crommelin D.J.A., Danhof M., and Boer A.G. Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res 21 5 (2004) 761-769
6. Pardridge W.M. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. Neurorx 2 1 (2005) 129-138
7. Jefferies W.A., Brandon M.R., Hunt S.V., Williams A.F., Gatter K.C., and Mason D.Y. Transferrin receptor on endothelium of brain capillaries. Nature 312 5990 (1984) 162-163
8. Pardridge W.M., Eisenberg J., and Yang J. Human blood-brain barrier transferrin receptor. Metabolism 36 9 (1987) 892-895
9. Aktas Y., Yemisci M., Andrieux K., Gursoy R.N., Alonso M.J., Fernandez-Megia E., et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 16 6 (2005) 1503-1511
10. Qian Z.M., Li H., Sun H., and Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54 4 (2002) 561-587
11. Ji B., Maeda J., Higuchi M., Inoue K., Akita H., Harashima H., et al. Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci 78 8 (2006) 851-855
12. Moos T., and Morgan E.H. Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat. J Neurochem 79 1 (2001) 119-129
13. Huang R.Q., Ke W.L., Qu Y.H., Zhu J.H., Pei Y.Y., and Jiang C. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. J Biomed Sci 14 1 (2007) 121-128
14. Ward P.P., Uribe-Luna S., and Conneely O.M. Lactoferrin and host defense. Biochem Cell Biol 80 1 (2002) 95-102
15. Suzuki Y.A., Lopez V., and Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 62 22 (2005) 2560-2575
16. Talukder M.J., Takeuchi T., and Harada E. Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J Vet Med Sci 65 9 (2003) 957-964
17. Suzuki Y.A., and Lonnerdal B. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse. Biometals 17 3 (2004) 301-309
18. Fillebeen C., Descamps L., Dehouck M.P., Fenart L., Benaissa M., Spik G., et al. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274 11 (1999) 7011-7017
19. Faucheux B.A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92 21 (1995) 9603-9607
20. Grau A.J., Willig V., Fogel W., and Werle E. Assessment of plasma lactoferrin in Parkinson's disease. Mov Disord 16 1 (2001) 131-134
21. Zhang X.Q., Wang X.L., Huang S.W., Zhuo R.X., Liu Z.L., Mao H.Q., et al. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core. Biomacromolecules 6 1 (2005) 341-350
22. Luo D., Haverstick K., Belcheva N., Han E., and Saltzman W.M. Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery. Macromolecules 35 9 (2002) 3456-3462
23. Braun C.S., Vetro J.A., Tomalia D.A., Koe G.S., Koe J.G., and Middaugh C.R. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci 94 2 (2005) 423-436
24. Xie Y., Ye L.Y., Zhang X.B., Cui W., Lou J.N., Nagai T., et al. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. J Control Release 105 1-2 (2005) 106-119
25. 125I by the conjugation method. Nucl Tech 19 (1996) 309-313
26. Lu W., Zhang Y., Tan Y.Z., Hu K.L., Jiang X.G., and Fu S.K. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107 3 (2005) 428-448
27. Ellmann G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 82 1 (1959) 70-77
28. Kang H., DeLong R., Fisher M.H., and Juliano R.L. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res 22 12 (2005) 2099-2106
29. Yang H., Morris J.J., and Lopina S.T. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Interface Sci 273 1 (2004) 148-154
30. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S., Coll J.L., Behr J.P., et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1 3 (1999) 210-222
31. Plank C., Mechtler K., Szoka F.C., and Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 7 12 (1996) 1437-1446
32. Dufès C., Uchegbu I.F., and Schätzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 57 15 (2005) 2177-2202
33. Chasteen N.D., and Woodworth R.C. Transferrin and lactoferrin. In: Ponka P., Schulman H.M., and Woodworth R.C. (Eds). Iron transport and storage (1990), CRC Press, Florida, Boca Raton 69-83
34. Huang R.Q., Qu Y.H., Ke W.L., Zhu J.H., Pei Y.Y., and Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 21 4 (2007) 1117-1125
35. Kobayashi H., Wu C., Kim M.K., Paik C.H., Carrasquillo J.A., and Brechbiel M.W. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-tac monoclonal antibody. Bioconjug Chem 10 1 (1999) 103-111